Pharmaessentia USA Corporation
Biopharmaceutical company that develops treatments for myeloproliferative neoplasms, more
Based in MA
AI Overview
With $160K in lobbying spend across 8 quarterly filings, Pharmaessentia USA Corporation is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $160K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Pharmaessentia USA Corporation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
Issues related to implementation of the Inflation Reduction Act (IRA, P. L. 117-169).
Issues related to implementation of the Inflation Reduction Act (IRA, P.L. 117-169).
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.